nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Bacterial toxins as tools for mucosal vaccination
|
Mrsny, Randall J. |
|
2002 |
7 |
4 |
p. 247-258 12 p. |
artikel |
2 |
Electronic DPI for insulin
|
Whelan, Jo |
|
2002 |
7 |
4 |
p. 213-214 2 p. |
artikel |
3 |
Evaluating R&D projects and portfolios
|
Porkolab, Lorant |
|
2002 |
7 |
4 |
p. 230-231 2 p. |
artikel |
4 |
Glutamate receptors and persistent pain: targeting forebrain NR2B subunits
|
Zhuo, Min |
|
2002 |
7 |
4 |
p. 259-267 9 p. |
artikel |
5 |
Ion channel screening technologies: will they revolutionize drug discovery?
|
Ebneth, Andreas |
|
2002 |
7 |
4 |
p. 227- 1 p. |
artikel |
6 |
Monitor: molecules and profiles
|
Langston, Steven |
|
2002 |
7 |
4 |
p. 268-269 2 p. |
artikel |
7 |
New promises for schizophrenia therapy
|
Sridhar, Nadamuni |
|
2002 |
7 |
4 |
p. 215-216 2 p. |
artikel |
8 |
News in brief
|
Clough, Joanne |
|
2002 |
7 |
4 |
p. 217-221 5 p. |
artikel |
9 |
New vaccines: damming for multi-strain organisms?
|
Fricker, Janet |
|
2002 |
7 |
4 |
p. 212-213 2 p. |
artikel |
10 |
Novel antitumour molecules
|
Westwell, Andrew D |
|
2002 |
7 |
4 |
p. 269-272 4 p. |
artikel |
11 |
People
|
Lawrence, Rebecca N |
|
2002 |
7 |
4 |
p. 221-222 2 p. |
artikel |
12 |
Safety pharmacology for the non-clinical assessment of medicinal products
|
MacKenzie, Ian |
|
2002 |
7 |
4 |
p. 232-234 3 p. |
artikel |
13 |
Target validation of G-protein coupled receptors
|
Wise, Alan |
|
2002 |
7 |
4 |
p. 235-246 12 p. |
artikel |
14 |
The utility of predictivity in drug discovery and use
|
Peet, Norton P |
|
2002 |
7 |
4 |
p. 228-229 2 p. |
artikel |
15 |
VEGF therapy in heart disease: for better or for worse?
|
Springer, Matthew L |
|
2002 |
7 |
4 |
p. 209-211 3 p. |
artikel |
16 |
William Pardridge discusses the lack of BBB research
|
Lawrence, Rebecca N |
|
2002 |
7 |
4 |
p. 223-226 4 p. |
artikel |